689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2

Bibliographic Details
Title: 689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2
Authors: Lien Vandenberk, Paula Rodríguez-Otero, Maria-Victoria Mateos, Ajai Chari, Bhagirathbhai Dholaria, Deeksha Vishwamitra, Sheri Skerget, M Damiette Smit, Kalpana Bakshi, Sangmin Lee, Nizar Bahlis, Niels WCJ van de Donk, Raluca Verona
Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Publisher Information: BMJ Publishing Group, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2023-SITC2023.0689
Access URL: https://doaj.org/article/dbff19d26aaa4728b508224666963930
Accession Number: edsdoj.bff19d26aaa4728b508224666963930
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2023-SITC2023.0689
Published in:Journal for ImmunoTherapy of Cancer
Language:English